182 related articles for article (PubMed ID: 23572011)
1. Hormonal contraceptive use and discontinuation among HIV-infected women in Uganda and Zimbabwe.
Bengtson A; Kwok C; Salata RA; Byamugisha J; Chipato T; Rwambuya S; Moyo P; Morrison CS
J Acquir Immune Defic Syndr; 2013 Aug; 63(4):506-13. PubMed ID: 23572011
[TBL] [Abstract][Full Text] [Related]
2. Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda, Zimbabwe and Thailand.
Nanda K; Morrison CS; Kwok C; Byamugisha J; Jones L; Sriplienchan S; Magwali T
Contraception; 2011 Jun; 83(6):542-8. PubMed ID: 21570552
[TBL] [Abstract][Full Text] [Related]
3. Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness.
Whiteman MK; Jeng G; Samarina A; Akatova N; Martirosyan M; Kissin DM; Curtis KM; Marchbanks PA; Hillis SD; Mandel MG; Jamieson DJ
Contraception; 2016 Jan; 93(1):17-24. PubMed ID: 26197261
[TBL] [Abstract][Full Text] [Related]
4. Hormonal contraception and the risk of HIV acquisition.
Morrison CS; Richardson BA; Mmiro F; Chipato T; Celentano DD; Luoto J; Mugerwa R; Padian N; Rugpao S; Brown JM; Cornelisse P; Salata RA;
AIDS; 2007 Jan; 21(1):85-95. PubMed ID: 17148972
[TBL] [Abstract][Full Text] [Related]
5. Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial.
Crook AM; Ford D; Gafos M; Hayes R; Kamali A; Kapiga S; Nunn A; Chisembele M; Ramjee G; Rees H; McCormack S
Hum Reprod; 2014 Aug; 29(8):1810-7. PubMed ID: 24838704
[TBL] [Abstract][Full Text] [Related]
6. Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe.
Morrison CS; Chen PL; Nankya I; Rinaldi A; Van Der Pol B; Ma YR; Chipato T; Mugerwa R; Dunbar M; Arts E; Salata RA
J Acquir Immune Defic Syndr; 2011 Jun; 57(2):157-64. PubMed ID: 21358412
[TBL] [Abstract][Full Text] [Related]
7. Responding to the ECHO trial results: modelling the potential impact of changing contraceptive method mix on HIV and reproductive health in South Africa.
Smith JA; Beacroft L; Abdullah F; Buthelezi B; Makua M; Morroni C; Ramjee G; Velasquez C; Hallett TB
J Int AIDS Soc; 2020 Oct; 23(10):e25620. PubMed ID: 33030312
[TBL] [Abstract][Full Text] [Related]
8. Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial.
Akello CA; Bunge KE; Nakabiito C; Mirembe BG; Fowler MG; Mishra A; Marrazzo J; Chirenje ZM; Celum C; Balkus JE
J Womens Health (Larchmt); 2017 Jun; 26(6):670-676. PubMed ID: 28437215
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy risk among oral contraceptive pill, injectable contraceptive, and condom users in Uganda, zimbabwe, and Thailand.
Steiner MJ; Kwok C; Dominik R; Byamugisha JK; Chipato T; Magwali T; Mmiro F; Rugpao S; Sriplienchan S; Morrison CS
Obstet Gynecol; 2007 Nov; 110(5):1003-9. PubMed ID: 17978111
[TBL] [Abstract][Full Text] [Related]
10. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies.
Jain AK
Contraception; 2012 Dec; 86(6):645-52. PubMed ID: 22541635
[TBL] [Abstract][Full Text] [Related]
11. Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.
Grabowski MK; Gray RH; Makumbi F; Kagaayi J; Redd AD; Kigozi G; Reynolds SJ; Nalugoda F; Lutalo T; Wawer MJ; Serwadda D; Quinn TC; Tobian AAR
Lancet Glob Health; 2015 Aug; 3(8):e478-e486. PubMed ID: 26094162
[TBL] [Abstract][Full Text] [Related]
12. Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression.
Morrison CS; Hofmeyr GJ; Thomas KK; Rees H; Philip N; Palanee-Phillips T; Nanda K; Nair G; Onono M; Mastro TD; Lind M; Heffron R; Edward V; Deese J; Beksinska M; Beesham I; Stringer JSA; Baeten JM; Ahmed K;
AIDS Res Hum Retroviruses; 2020 Aug; 36(8):632-640. PubMed ID: 32394723
[TBL] [Abstract][Full Text] [Related]
13. The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.
Fichorova RN; Chen PL; Morrison CS; Doncel GF; Mendonca K; Kwok C; Chipato T; Salata R; Mauck C
mBio; 2015 Sep; 6(5):e00221-15. PubMed ID: 26330510
[TBL] [Abstract][Full Text] [Related]
14. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
[TBL] [Abstract][Full Text] [Related]
15. Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.
Balkus JE; Brown ER; Hillier SL; Coletti A; Ramjee G; Mgodi N; Makanani B; Reid C; Martinson F; Soto-Torres L; Abdool Karim SS; Chirenje ZM
Contraception; 2016 Jan; 93(1):25-31. PubMed ID: 26519646
[TBL] [Abstract][Full Text] [Related]
16. Intramuscular depot medroxyprogesterone acetate accentuates bone loss associated with tenofovir disoproxil fumarate-containing antiretroviral therapy initiation in young women living with HIV (the BONE: CARE study): a prospective cohort study in Uganda.
Kiweewa Matovu F; Kiwanuka N; Nabwana M; Scholes D; Musoke P; Glenn Fowler M; Beksinska ME; Pettifor JM; Brown TT;
Lancet Glob Health; 2022 May; 10(5):e694-e704. PubMed ID: 35427526
[TBL] [Abstract][Full Text] [Related]
17. Preference for Sayana® Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial.
Polis CB; Nakigozi GF; Nakawooya H; Mondo G; Makumbi F; Gray RH;
Contraception; 2014 May; 89(5):385-95. PubMed ID: 24332432
[TBL] [Abstract][Full Text] [Related]
18. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
Polaneczky M; Guarnaccia M; Alon J; Wiley J
Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283
[TBL] [Abstract][Full Text] [Related]
19. Reasons for contraceptive discontinuation in women 20-39 years old in New Zealand.
Colli E; Tong D; Penhallegon R; Parazzini F
Contraception; 1999 Apr; 59(4):227-31. PubMed ID: 10457866
[TBL] [Abstract][Full Text] [Related]
20. Effects of hormonal contraceptive use on HIV acquisition and transmission among HIV-discordant couples.
Lutalo T; Musoke R; Kong X; Makumbi F; Serwadda D; Nalugoda F; Kigozi G; Sewankambo N; Sekasanvu J; Wawer M; Gray R
AIDS; 2013 Oct; 27 Suppl 1():S27-34. PubMed ID: 24088681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
